Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial : Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 03. Mai Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Phase: Phase 2
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 11-01-2021, Last updated: 2022-11-24

ICTRP ID:

EUCTR2020-005887-70-CZ
REMED

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007582765